已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Supplementation with a β-glucan tablet has no effect on hyperlipidemia: a randomized, placebo-controlled clinical trial

高脂血症 安慰剂 医学 胆固醇 载脂蛋白B 内科学 葡聚糖 脂蛋白 内分泌学 血脂谱 高密度脂蛋白 胃肠病学 化学 生物化学 糖尿病 病理 替代医学
作者
Victoria Rioux-Labrecque,Mariève Cossette,Marianne Rufiange,Denis Bilodeau,Marie‐Claude Guertin,Jean‐Claude Tardif
出处
期刊:The American Journal of Clinical Nutrition [Elsevier BV]
卷期号:117 (6): 1232-1239 被引量:3
标识
DOI:10.1016/j.ajcnut.2023.04.012
摘要

Clinical evidence has suggested that the oat-soluble fiber β-glucan might have lipid-lowering effects.The present clinical trial was conducted to evaluate the efficacy and safety of high-medium molecular weight β-glucan on serum low-density lipoprotein (LDL) cholesterol and other lipid subfractions in subjects with hyperlipidemia.A randomized double-blinded trial was performed to assess the efficacy and safety of β-glucan supplementation in reducing lipid levels. Subjects with LDL cholesterol levels of >3.37 mmol/L when treated or not with a statin were randomly assigned to receive 1 of 3 daily doses of a tableted formulation of β-glucan (1.5, 3, or 6 g) or placebo. The primary efficacy end point was the change from baseline to 12 wk in LDL cholesterol. Secondary end points of lipid subfractions and safety were also assessed.A total of 263 subjects were enrolled; 66 subjects were assigned to each of the 3 β-glucan groups, and 65 subjects were assigned to the placebo group. The mean change from baseline to 12 wk in serum LDL cholesterol level was 0.08, 0.11, and -0.04 mmol/L in the 3 β-glucan groups (P = 0.23, 0.18, and 0.72 compared with the placebo group, respectively) and -0.10 mmol/L in the placebo group. The changes in total cholesterol, small LDL cholesterol subclass particle concentration, non-high-density lipoprotein cholesterol, apolipoprotein B, very low-density lipoprotein cholesterol, and high-sensitivity C-reactive protein were also not significant in the β-glucan groups when compared with the placebo group. Gastrointestinal adverse events were reported in 23.4%, 34.8%, and 66.7% of patients in the β-glucan groups and in 36.9% of patients in the placebo group (P < 0.0001 for the overall comparison across the 4 groups).In subjects with LDL cholesterol levels of >3.37 mmol/L, a tablet formulation of β-glucan was not effective in reducing LDL cholesterol concentration or other lipid subfractions when compared with a placebo. This trial was registered at clinicaltrials.gov as NCT03857256.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Orange应助XU采纳,获得10
刚刚
momo发布了新的文献求助30
1秒前
4秒前
香蕉觅云应助俏皮的白柏采纳,获得10
4秒前
纸包鱼发布了新的文献求助30
6秒前
Rondab应助一颗椰子糖耶采纳,获得10
8秒前
燕子发布了新的文献求助10
8秒前
9秒前
Hello应助小猪佩奇采纳,获得10
10秒前
脆脆鲨完成签到,获得积分10
11秒前
彭于晏应助PMoLGGYM2021采纳,获得10
11秒前
13秒前
大模型应助小柴柴采纳,获得10
13秒前
小橘猫发布了新的文献求助10
14秒前
15秒前
山奈完成签到,获得积分10
18秒前
19秒前
赘婿应助迷你的颖采纳,获得10
19秒前
虚心月饼发布了新的文献求助10
19秒前
23秒前
23秒前
培乐多发布了新的文献求助10
24秒前
24秒前
25秒前
25秒前
26秒前
iNk应助niuma采纳,获得20
28秒前
28秒前
Xangel发布了新的文献求助10
30秒前
31秒前
kannakaco完成签到,获得积分10
31秒前
31秒前
xxxrass完成签到,获得积分20
31秒前
时闲发布了新的文献求助10
31秒前
小橘猫完成签到,获得积分10
32秒前
Rondab应助tonyguo采纳,获得10
33秒前
33秒前
培乐多完成签到,获得积分10
34秒前
斑鸠完成签到,获得积分10
34秒前
顾矜应助俏皮的白柏采纳,获得10
34秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989811
求助须知:如何正确求助?哪些是违规求助? 3531927
关于积分的说明 11255560
捐赠科研通 3270706
什么是DOI,文献DOI怎么找? 1805035
邀请新用户注册赠送积分活动 882181
科研通“疑难数据库(出版商)”最低求助积分说明 809190